Aceragen Competitors and Similar CompaniesClear all
Aceragen's competitors and similar companies include Biothera and Novartis Gene Therapies.
 Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. |  Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. |  Novartis Gene Therapies Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases. | |
Founding Date | Founding Date 1989 | Founding Date 1997 | Founding Date 2010 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Durham, US HQ | Locations Roseville, US HQ | Locations Bannockburn, US HQ |
Employees | Employees 3642% decrease | Employees 542% increase | Employees 6603% decrease |
Financial | |||
Net income | Net income ($23.4m) (FY, 2022) | Net income N/A | Net income ($218.1m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 13.8m | Total funding raised $ 5.1m | Total funding raised $ 75m |
For sources of this data, please see the company profile
View Company Profiles
Biothera
HQ
Roseville, US
Employees
54↑ 2% increase
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View companyNovartis Gene Therapies
HQ
Bannockburn, US
Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
View company